URL has been copied successfully!
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
- BTIG cut the price target for Abbott Laboratories (NYSE:ABT) from $140 to $131. BTIG analyst Marie Thibault maintained a Buy rating. Abbott shares closed at $101.88 on Monday. See how other analysts view this stock.
- HC Wainwright & Co. cut BTCS Inc. (NASDAQ:BTCS) price target from $7 to $5. HC Wainwright & Co. analyst Kevin Dede maintained a Buy rating. BTCS shares closed at $1.29 on Monday. See how other analysts view this stock.
- Needham slashed price target for Phreesia, Inc. (NYSE:PHR) from $35 to $14. Needham analyst Ryan MacDonald maintained a Buy rating. Phreesia shares closed at $11.41 on Monday. See how other analysts view this stock.
- HC Wainwright & Co. raised the price target for Bicara Therapeutics Inc.
Please follow us:
This post was originally published here
